Home » Topics » Regulatory » Patents

Patents
RSS

Actelion patents novel dual orexin OX1/OX2 receptor antagonists for eating disorders

Nov. 21, 2007

Recent Novartis patent discloses novel agents for renal failure

Nov. 21, 2007

Novel therapeutic agents for respiratory and allergic disorders described in recent patents

Nov. 21, 2007

Novel antiobesity agents described in recent patent literature

Nov. 20, 2007

New agents for treating neurological disorders disclosed in recent patent literature

Nov. 19, 2007

Novel antiatherosclerotic agents emerge from Merck & Co. R&D

Nov. 19, 2007

Recent GSK patent discloses new therapeutic agents for cachexia

Nov. 16, 2007

Novel treatment for inflammatory disorders claimed in recent AstraZeneca patent

Nov. 16, 2007

New therapeutic agents for metabolic disorders described in recent patents

Nov. 16, 2007

New antiinflammatory agents disclosed in recent Kalypsys and Abbott patents

Nov. 15, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....